| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,664,000 | 2,834,000 | 2,812,000 | 3,536,000 | | Cost of Revenue | 4,572,000 | 912,000 | 927,000 | 1,156,000 | | | Gross Profit | (908,000) | 1,922,000 | 1,885,000 | 2,380,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (2,731,000) | 1,762,000 | 969,000 | 1,179,000 | | Non Recurring |
-
| 867,000 | 21,000 | 31,000 | | Others | 1,053,000 | (342,000) | 342,000 | 706,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 770,000 | (365,000) | 553,000 | 464,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 59,000 | 30,000 | 30,000 | 43,000 | | Earnings Before Interest And Taxes | 865,000 | (329,000) | 575,000 | 498,000 | | Interest Expense | 187,000 | 182,000 | 187,000 | 189,000 | | Income Before Tax | 678,000 | (511,000) | 388,000 | 309,000 | | Income Tax Expense | 233,000 | (524,000) | 122,000 | 75,000 | | Minority Interest |
-
|
-
|
-
| (18,000) | | | | Net Income From Continuing Ops | 445,000 | 13,000 | 266,000 | 216,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (7,000) | 3,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 362,000 | 6,000 | 269,000 | 216,000 | | Preferred Stock And Other Adjustments | 41,000 | (22,000) | (19,000) |
-
| | | Net Income Applicable To Common Shares | $403,000 | ($16,000) | $250,000 | $216,000 |
|
0.31% Nasdaq 
0.05%
Income Statement
